BioAge Labs Inc. (BIOA) vs High Tide Inc. (HITI)
A side-by-side comparison of BioAge Labs Inc. and High Tide Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIOA
BioAge Labs Inc.
$6.27HealthcareDelayed quote: Oct 6, 2026, 11:50 AM EDT
HITI
High Tide Inc.
$2.71HealthcareDelayed quote: Oct 6, 2026, 11:48 AM EDT
Total return — BIOA vs HITI
growth of $100 · dividends reinvested · last 2yBIOA -65.3% (-41.1%/yr)HITI +40.0% (+18.3%/yr)HITI compounded faster over this window
BIOA HITI
BIOA vs HITI: by the numbers
- •HITI is the larger company ($238M vs $236M market cap).
- •Both run net losses; HITI's is the smaller (-4.52% vs -912.25% net margin).
Metrics side by side
Valuation
| Metric | BIOA | HITI |
|---|---|---|
| P/S ratio | 22.80 | 0.45 |
| P/B ratio | 0.63 | 3.17 |
| EV / EBITDA | N/A | 12.82 |
| FCF yield | N/A | 4.83% |
Profitability
| Metric | BIOA | HITI |
|---|---|---|
| Gross margin | 99.39% | 25.85% |
| Operating margin | -1026.28% | 0.56% |
| Net margin | -912.25% | -4.52% |
| ROE | -25.20% | -31.55% |
| ROIC | -28.14% | 1.38% |
Growth (annualized)
| Metric | BIOA | HITI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 33.84% |
| Total return CAGR (5Y) | N/A | -14.29% |
Go deeper
Dig into the metrics
BioAge Labs ROEHigh Tide ROEBioAge Labs operating marginHigh Tide operating marginBioAge Labs revenue growthHigh Tide revenue growthBioAge Labs free cash flowHigh Tide free cash flow
BioAge Labs & High Tide appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.